This session will provide updates on anaphylaxis identification and management, specifically discussing the new practice parameters and workgroup report.

Upon completion of this activity, participants should be able to:

  • Describe challenges in identifying and managing anaphylaxis
  • Discuss updates from the new anaphylaxis practice parameters
  • Outline the evidence base for epinephrine in the treatment of anaphylaxis


Moderator Introduction
Roland Solensky, MD FAAAAI
The Corvallis Clinic

Epinephrine for Anaphylaxis: What Do We Know and What Do We Need?
David  B. Golden, MD FAAAAI
Johns Hopkins University

Please take a moment to click the link below and give us your feedback on this session: